|Atossa Genetics, Inc.|
2345 Eastlake Avenue East
United States - Map
Atossa Genetics Inc. operates as a healthcare company that focuses on the development of a suite of laboratory services, medical devices, and therapeutics for breast cancer in the United States. The company markets nipple aspirate fluid (NAF) cytology tests and pharmacogenomics tests. Its medical devices include the ForeCYTE Breast Aspirator and the FullCYTE Breast Aspirator devices that are intended for the collection of NAF for cytological testing at a laboratory. The company is also involved in the development of other devices comprising intraductal microcatheters for the collection of ductal lavage fluid and for the potential administration of a targeted therapeutic, as well as various tools for potential use by breast surgeons. Atossa Genetics Inc. was founded in 2009 and is headquartered in Seattle, Washington.
|Dr. Steven C. Quay M.D., Ph.D., FCAP,
Chairman, Chief Exec. Officer, Pres and Treasurer
|Mr. Kyle Guse Esq., CPA,
Chief Financial Officer, Gen. Counsel and Sec.
|Dr. Shu-Chih Chen Ph.D.,
Chief Scientific Officer and Director
|Mr. Scott Youmans ,
Sr. VP of Operations
|Ms. Cindy Atha ,
VP of Sales and Marketing
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|